667 related articles for article (PubMed ID: 26245885)
1. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
Ramos-Remus C; Castillo-Ortiz JD; Aguilar-Lozano L; Padilla-Ibarra J; Sandoval-Castro C; Vargas-Serafin CO; de la Mora-Molina H; Ramos-Gomez A; Sanchez-Ortiz A; Avila-Armengol H; Aceves-Avila FJ
Arthritis Rheumatol; 2015 Nov; 67(11):2837-44. PubMed ID: 26245885
[TBL] [Abstract][Full Text] [Related]
2. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
[TBL] [Abstract][Full Text] [Related]
3. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
4. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
6. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
7. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
11. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
Gossec L; Paternotte S; Combe B; Meyer O; Dougados M
J Rheumatol; 2014 Jan; 41(1):41-6. PubMed ID: 24241481
[TBL] [Abstract][Full Text] [Related]
12. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
15. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S
Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362
[TBL] [Abstract][Full Text] [Related]
16. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
Cho SY; Kang SY; Lee HJ; Lee WI
Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.
Gomez EL; Gun SC; Somnath SD; D'Souza B; Lim AL; Chinna K; Radhakrishnan AK
Int J Rheum Dis; 2011 Feb; 14(1):12-7. PubMed ID: 21303477
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis.
Kobak S; Ylmaz H; Sever F; Duran A; Sen N
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):206-10. PubMed ID: 25363220
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
